Founder mutation for Huntington disease in Caucasus Jews

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0004|87|2|167-172

ISSN： 0009-9163

Source： CLINICAL GENETICS, Vol.87, Iss.2, 2015-02, pp. : 167-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Consanguinity and founder effect for Gaucher disease mutation G377S in a population from Tabuleiro do Norte, Northeastern Brazil

By  

CLINICAL GENETICS, Vol. 88, Iss. 4, 2015-10 ,pp. : 391-395

John Wiley & Sons Inc

Access to resources Recommend Favorite

Consanguinity and founder effect for Gaucher disease mutation G377S in a population from Tabuleiro do Norte, Northeastern Brazil

By  

CLINICAL GENETICS, Vol. 9-9163, Iss. 4, 2015-10 ,pp. : 391-395

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neuropsychiatric Burden in Huntington’s Disease

By Paoli Ricardo Augusto   Botturi Andrea   Ciammola Andrea   Silani Vincenzo   Prunas Cecilia   Lucchiari Claudio   Zugno Elisa   Caletti Elisabetta  

Brain Sciences, Vol. 7, Iss. 6, 2017-06 ,pp. : 67-67

MDPI

Access to resources Recommend Favorite

A founder mutation in the TCIRG1 gene causes osteopetrosis in the Ashkenazi Jewish population

By  

CLINICAL GENETICS, Vol. 88, Iss. 1, 2015-07 ,pp. : 74-79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is the ubiquitin-proteasome system impaired in Huntington’s disease?

By Ortega Z.   Díaz-Hernández M.   Lucas J.  

Cellular and Molecular Life Sciences CMLS, Vol. 64, Iss. 17, 2007-09 ,pp. : 2245-2257

Springer Publishing Company

Access to resources Recommend Favorite